FINNENCE ▪ THE WIRE FILE
THE WIRE · № 79870
News■ Unclear/unknown
Attorney Tracy Paulsen Brings Focused Experience to Growing GLP-1 Vision Loss and NAION Litigation
KINDNews
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN
LAST UPDATE
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Litigation marketing around GLP-1 side effects; no named defendant or listed issuer.
GLP-1 litigation noise, no ticker
CATALYST TO WATCH
None identified in text
MAIN RISK
No defendant or issuer named
FULL DISPATCH
Massachusetts attorney represents individuals across the Northeast who were diagnosed with NAION after using GLP-1 medications as federal litigation continues to expand. ATTLEBORO, Mass., Oct. 14, 2026 /PRNewswire/ -- Rightful Legal, P.C. founder and attorney Tracy Paulsen is representing...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
Proposed 2027 Medicare Cuts Threaten Seniors' Access to Care Amid Growing Physician Shortage2026-10-14 14:28 UTC
Proposed 2027 Medicare Cuts Threaten Seniors' Access to Care Amid Growing Physician Shortage2026-10-14 14:28 UTC
←CORRELATIONshares Healthcare
Vector Science & Therapeutics Corp. Appoints Russell Starr as President2026-10-14 11:30 UTC
Vector Science & Therapeutics Corp. Appoints Russell Starr as President2026-10-14 11:30 UTC
←CORRELATIONshares Healthcare
New Phase 3 trial: A Study of Lebrikizumab in Adults and Adolescents With Face and Neck Atopic Dermatitis — Almirall, S.A.2026-10-14 12:00 UTC
New Phase 3 trial: A Study of Lebrikizumab in Adults and Adolescents With Face and Neck Atopic Dermatitis — Almirall, S.A.2026-10-14 12:00 UTC
←CORRELATIONshares Healthcare
Phase 3 results posted: A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome — Hoffmann-La Roche2026-10-14 12:00 UTC
Phase 3 results posted: A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome — Hoffmann-La Roche2026-10-14 12:00 UTC
←CORRELATIONshares Healthcare
Phase 3 results posted: A Study of Adeno-Associated Virus Serotype 8-Mediated Gene Transfer of Glucose-6-Phosphatase in Patients With Glycogen Storage Disease Type Ia (GSDIa) — Ultragenyx Pharmaceutical Inc2026-10-14 12:00 UTC
Phase 3 results posted: A Study of Adeno-Associated Virus Serotype 8-Mediated Gene Transfer of Glucose-6-Phosphatase in Patients With Glycogen Storage Disease Type Ia (GSDIa) — Ultragenyx Pharmaceutical Inc2026-10-14 12:00 UTC
←CORRELATIONshares Healthcare
New Survey: 76% of People Say Health Care Is A Top Three Issue Determining Their Vote2026-10-14 12:09 UTC
New Survey: 76% of People Say Health Care Is A Top Three Issue Determining Their Vote2026-10-14 12:09 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.